Scout | Biology of Bladder Cancer (R21 Clinical Trial Optional)

This opportunity is no longer accepting applications.

grant

Biology of Bladder Cancer (R21 Clinical Trial Optional)

This grant opportunity is for research on the biology and mechanisms behind bladder cancer. Bladder cancer poses a large health challenge due to its high occurrence and tendency to recur. There have been advances in understanding the genetic mutations associated with bladder cancer, but less is known about the molecular processes that drive its development and progression. Additionally, there'…

Source

Agency: National Institutes of Health

Sub-agency: National Cancer Institute

Program: SBIR

Award

Award Ceiling: $275,000

Funding Amount: $275,000

Dates

Open for Submission: July 26, 2022

Submission Deadline: September 7, 2025

Application Window Closes: September 7, 2025

Opportunity Released: July 26, 2022

Keywords

Bladder cancer

Molecular mechanisms

Tumor recurrence

Cancer biology

Molecular profiling

Mutated genes

Multidisciplinary research

Clinical specimens

Cancer progression

Cancer interventions

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers